Law360, New York (April 06, 2010, 6:00 PM ET) -- The U.S. Court of Appeals for the Eleventh Circuit has upheld AstraZeneca Pharmaceuticals LP's victory against one of the trial pool plaintiffs in the multidistrict litigation over the company's antipsychotic medication Seroquel, agreeing with a district court that the testimony of the plaintiff's key expert was inadmissible.
A three-judge panel said in a per curiam opinion Tuesday that Linda Guinn, whose case against AstraZeneca was chosen for an early trial but came to a halt when AstraZeneca won a motion for summary judgment, couldn't use the...
AstraZeneca Win In Seroquel Bellwether Affirmed
To view the full article, take a free trial now.
